NPPB and metabolic syndrome: In Table 5, patients with dyslipidemia (n = 54) had significantly lower EF (26.72% ± 5.37 vs. 29.18% ± 4.75, p = 0.02), higher PWV (13.51 ± 1.77 vs. 12.43 ± 1.66, p < 0.01), and higher NT-proBNP levels (10,012.65 ± 4428.24 vs. 7267.02 ± 2204.54, p < 0.01) compared to patients without dyslipidemia (n = 44).